https://doi.org/10.1016/s1473-3099(19)30550-x
E
Enock Kagimu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
743
Citations
15
h-index
19
i10-index
Enock Kagimu is an academic researcher from Infectious Diseases Institute. The author has contributed to research in topics: Infectious Diseases and Tuberculosis & Fungal Infections and Studies & Antifungal resistance and susceptibility. The author has an h-index of 15, co-authored 44 publications.
ORCID: 0000-0002-0291-651XPapers by this author
worksXpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study
2020 · The Lancet Infectious Diseases · 115 citations
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
2023 · Clinical Infectious Diseases · 55 citations
https://doi.org/10.1093/cid/ciad440
Tuberculosis preventive therapy (TPT) to prevent tuberculosis co-infection among adults with HIV-associated cryptococcal meningitis: A clinician’s perspective
2020 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 9 citations
https://doi.org/10.1016/j.jctube.2020.100180
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort Study
2024 · Clinical Infectious Diseases · 6 citations
https://doi.org/10.1093/cid/ciae413
Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial
2025 · Clinical Infectious Diseases · 1 citations
https://doi.org/10.1093/cid/ciaf432
Distal jejunal obstruction due to Cryptococcus neoformans and rifampicin-resistant Mycobacterium tuberculosis co-infection: A case report
2022 · Medical Mycology Case Reports · 0 citations
https://doi.org/10.1016/j.mmcr.2022.10.006
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat